Literature DB >> 19309197

Continuation-phase cognitive therapy's effects on remission and recovery from depression.

Jeffrey R Vittengl1, Lee Anna Clark, Robin B Jarrett.   

Abstract

The authors tested the effects of continuation-phase cognitive therapy (C-CT) on remission and recovery from recurrent major depressive disorder, defined as 6 weeks and 8 months, respectively, of continuously absent or minimal symptoms. Responders to acute-phase cognitive therapy were randomized to 8 months of C-CT (n = 41) or assessment control (n = 43), and they were followed 16 additional months (R. B. Jarrett et al., 2001). Relative to controls, a few more patients in C-CT remitted (88% vs. 97%), and significantly more recovered (62% vs. 84%). All patients without remission and recovery relapsed, but most patients who remitted (60%) and who recovered (75%) did not later relapse or recur. The authors discuss the importance of defining efficacious treatment as producing remission and recovery.

Entities:  

Mesh:

Year:  2009        PMID: 19309197      PMCID: PMC3785229          DOI: 10.1037/a0015238

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  20 in total

1.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

2.  Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression.

Authors:  Sona Dimidjian; Steven D Hollon; Keith S Dobson; Karen B Schmaling; Robert J Kohlenberg; Michael E Addis; Robert Gallop; Joseph B McGlinchey; David K Markley; Jackie K Gollan; David C Atkins; David L Dunner; Neil S Jacobson
Journal:  J Consult Clin Psychol       Date:  2006-08

3.  Cognitive therapy vs medications in the treatment of moderate to severe depression.

Authors:  Robert J DeRubeis; Steven D Hollon; Jay D Amsterdam; Richard C Shelton; Paula R Young; Ronald M Salomon; John P O'Reardon; Margaret L Lovett; Madeline M Gladis; Laurel L Brown; Robert Gallop
Journal:  Arch Gen Psychiatry       Date:  2005-04

4.  Prevention of relapse following cognitive therapy vs medications in moderate to severe depression.

Authors:  Steven D Hollon; Robert J DeRubeis; Richard C Shelton; Jay D Amsterdam; Ronald M Salomon; John P O'Reardon; Margaret L Lovett; Paula R Young; Kirsten L Haman; Brent B Freeman; Robert Gallop
Journal:  Arch Gen Psychiatry       Date:  2005-04

5.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

Review 6.  The empirical status of cognitive-behavioral therapy: a review of meta-analyses.

Authors:  Andrew C Butler; Jason E Chapman; Evan M Forman; Aaron T Beck
Journal:  Clin Psychol Rev       Date:  2005-09-30

7.  Recurrence after recovery from major depressive disorder during 15 years of observational follow-up.

Authors:  T I Mueller; A C Leon; M B Keller; D A Solomon; J Endicott; W Coryell; M Warshaw; J D Maser
Journal:  Am J Psychiatry       Date:  1999-07       Impact factor: 18.112

8.  Psychosocial disability during the long-term course of unipolar major depressive disorder.

Authors:  L L Judd; H S Akiskal; P J Zeller; M Paulus; A C Leon; J D Maser; J Endicott; W Coryell; J L Kunovac; T I Mueller; J P Rice; M B Keller
Journal:  Arch Gen Psychiatry       Date:  2000-04

9.  Course of depressive symptoms over follow-up. Findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program.

Authors:  M T Shea; I Elkin; S D Imber; S M Sotsky; J T Watkins; J F Collins; P A Pilkonis; E Beckham; D R Glass; R T Dolan
Journal:  Arch Gen Psychiatry       Date:  1992-10

10.  The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies.

Authors:  M B Keller; P W Lavori; B Friedman; E Nielsen; J Endicott; P McDonald-Scott; N C Andreasen
Journal:  Arch Gen Psychiatry       Date:  1987-06
View more
  9 in total

Review 1.  A systematic review of the combined use of electroconvulsive therapy and psychotherapy for depression.

Authors:  Shawn M McClintock; Anna R Brandon; Mustafa M Husain; Robin B Jarrett
Journal:  J ECT       Date:  2011-09       Impact factor: 3.635

2.  Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults.

Authors:  Katja Machmutow; Ramona Meister; Alessa Jansen; Levente Kriston; Birgit Watzke; Martin Christian Härter; Sarah Liebherz
Journal:  Cochrane Database Syst Rev       Date:  2019-05-20

3.  Prevention of recurrence of major depression among emerging adults by a group cognitive-behavioral/interpersonal intervention.

Authors:  Erin S Sheets; Linda Wilcoxon Craighead; Alisha L Brosse; Monika Hauser; Joshua W Madsen; W Edward Craighead
Journal:  J Affect Disord       Date:  2012-09-27       Impact factor: 4.839

Review 4.  Major depressive disorder: new clinical, neurobiological, and treatment perspectives.

Authors:  David J Kupfer; Ellen Frank; Mary L Phillips
Journal:  Lancet       Date:  2011-12-19       Impact factor: 79.321

5.  Stable remission and recovery after acute-phase cognitive therapy for recurrent major depressive disorder.

Authors:  Jeffrey R Vittengl; Lee Anna Clark; Michael E Thase; Robin B Jarrett
Journal:  J Consult Clin Psychol       Date:  2014-07-21

Review 6.  Long-term treatment of pediatric depression with psychotherapies.

Authors:  Zheya Jenny Yu; Mira Mooreville; Ronald A Weller; Elizabeth B Weller
Journal:  Curr Psychiatry Rep       Date:  2011-04       Impact factor: 5.285

7.  Predictors of longitudinal outcomes after unstable response to acute-phase cognitive therapy for major depressive disorder.

Authors:  Jeffrey R Vittengl; Lee Anna Clark; Michael E Thase; Robin B Jarrett
Journal:  Psychotherapy (Chic)       Date:  2015-06

8.  Change in psychosocial functioning and depressive symptoms during acute-phase cognitive therapy for depression.

Authors:  T W Dunn; J R Vittengl; L A Clark; T Carmody; M E Thase; R B Jarrett
Journal:  Psychol Med       Date:  2011-07-25       Impact factor: 7.723

9.  Moderators of continuation phase cognitive therapy's effects on relapse, recurrence, remission, and recovery from depression.

Authors:  Jeffrey R Vittengl; Lee Anna Clark; Robin B Jarrett
Journal:  Behav Res Ther       Date:  2010-02-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.